MaxCyte, Inc. Revenue Breakdown
No Revenue Breakdown for MXCT on this site yet.
- 2025-12-31: Others Not split by product in the filing$20.96M100.00%; Total revenue $20.96M.
- 2024-12-31: Others Not split by product in the filing$22.21M100.00%; Total revenue $22.21M.
- 2023-12-31: Others Not split by product in the filing$19.50M100.00%; Total revenue $19.50M.
- 2022-12-31: Others Not split by product in the filing$28.75M100.00%; Total revenue $28.75M.
Source checked: the stored Revenue Breakdown page for MXCT.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $20.96M 100.00% | $20.96M |
| 2024-12-31 | Not split by product in the filing $22.21M 100.00% | $22.21M |
| 2023-12-31 | Not split by product in the filing $19.50M 100.00% | $19.50M |
| 2022-12-31 | Not split by product in the filing $28.75M 100.00% | $28.75M |
| 2021-12-31 | Not split by product in the filing $21.57M 100.00% | $21.57M |
| 2020-12-31 | Not split by product in the filing $15.45M 100.00% | $15.45M |
| 2019-12-31 | Not split by product in the filing $13.26M 100.00% | $13.26M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $4.94M 100.00% | $4.94M |
| 2026-03-31 | Not split by product $4.50M 100.00% | $4.50M |
| 2025-12-31 | Not split by product $4.79M 100.00% | $4.79M |
| 2025-09-30 | Not split by product $4.60M 100.00% | $4.60M |
| 2025-06-30 | Not split by product $5.82M 100.00% | $5.82M |
| 2025-03-31 | Not split by product $5.74M 100.00% | $5.74M |
| 2024-12-31 | Not split by product $6.05M 100.00% | $6.05M |
| 2024-09-30 | Not split by product $5.61M 100.00% | $5.61M |
| 2024-06-30 | Not split by product $4.96M 100.00% | $4.96M |
| 2024-03-31 | Not split by product $5.58M 100.00% | $5.58M |
| 2023-12-31 | Not split by product $4.76M 100.00% | $4.76M |
| 2023-09-30 | Not split by product $4.16M 100.00% | $4.16M |
| 2023-06-30 | Not split by product $5.62M 100.00% | $5.62M |
| 2023-03-31 | Not split by product $4.96M 100.00% | $4.96M |
| 2022-12-31 | Not split by product $7.76M 100.00% | $7.76M |
| 2022-09-30 | Not split by product $7.15M 100.00% | $7.15M |
| 2022-06-30 | Not split by product $6.98M 100.00% | $6.98M |
| 2022-03-31 | Not split by product $6.86M 100.00% | $6.86M |
| 2021-12-31 | Not split by product $7.51M 100.00% | $7.51M |
| 2021-09-30 | Not split by product $5.61M 100.00% | $5.61M |
| 2021-06-30 | Not split by product $4.22M 100.00% | $4.22M |
| 2021-03-31 | Not split by product $4.24M 100.00% | $4.24M |
| 2020-12-31 | Not split by product $5.14M 100.00% | $5.14M |
| 2020-09-30 | Not split by product $4.67M 100.00% | $4.67M |
| 2020-06-30 | Not split by product $2.33M 100.00% | $2.33M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |